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In a comprehensive review of the evidence available in 1984,
Marmot concluded that moderate alcohol intake was associated
with decreased coronary heart disease (CHD) mortality while
heavy drinking resulted in higher mortality compared to 
non-drinkers.1 The consistency of the findings across ecological,
case-control and prospective studies and the availability of
convincing data on plausible mechanisms suggested a cardio-
protective effect of moderate alcohol consumption. However,
Marmot warned that increased intake was not recommended in
view of the social and medical consequences of an increase of
alcohol consumption in the population. Epidemiological data
published since this review support the original conclusions 
by Marmot and have provided further information to fine tune
our understanding of the relation of alcohol to CHD and their
relevance to policy.
Large prospective cohort studies have provided further 
solid data since 1984. Cohorts among middle-aged or elderly
people included, for example, 51 529 American male health
professionals with information on alcohol consumption studied
for 12 years,2 87 526 American female nurses followed for 
4 years,3 276 802 men enrolled by the American Cancer Society
followed for 12 years,4 490 000 American men and women
from the American Cancer Study II followed for 9 years,5
123 840 American adults from a prepaid health plan followed
for 8 years,6 12 321 British male doctors followed for 13 years,7
36 250 middle-aged French men followed 12–18 years8 or 
13 285 Danish men and women followed for an average of 
13.5 years.9 These and most other studies and reviews10–14
have consistently found that consumption of 1–6 drinks a 
day was associated with a 20–50% lower risk of CHD. (One
120–150 ml glass of wine, one 280–360 ml bottle/can of light
beer or one 20–30 ml measure of spirit each typically corres-
pond to one ‘unit’ or ‘drink’ and contain 10–17 ml alcohol or
8–15 g of alcohol). Moderate alcohol intake has also been asso-
ciated with a 20–30% reduced risk of stroke and other cardio-
vascular diseases5,7 and a 20% reduced risk of sudden death.15
Consistency of results among various populations and analytical
control for several potential confounders in many of these
studies makes it very unlikely that the apparent inverse relation
between alcohol intake and CHD results from selection biases or
confounding factors. In particular, results were generally not
substantially altered in analyses excluding people with illnesses
or abnormal risk factor levels at baseline. This argues against 
the view that higher mortality in non-drinkers relates to the
inclusion of sick people (including former drinkers) into the
categories of non-drinkers.16 Although ethical and feasibility issues
preclude the conduct of clinical trials of alcohol consumption, cur-
rent epidemiological evidence supports, virtually irrefutably, that
light-to-moderate drinking substantially reduces the risk of CHD.
The effects of moderate alcohol consumption on all-cause
mortality depends on a person’s underlying (or absolute) risk 
734 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
25 Fillmore KM, Golding JM, Graves KL et al. Alcohol consumption 
and mortality. 1. Characteristics of drinking groups. Addiction 1998;
93:183–203.
26 Leino E, Romelsjo A, Shoemaker C et al. Alcohol consumption and
mortality. 2. Studies of male populations. Addiction 1998;93:205–18.
27 Murray C, Lopez ADE. The Global Burden of Disease. Boston: Harvard
University Press, 1996.
28 Shaper AG, Wannamethee G, Walker M. Alcohol and mortality:
explainin© International Epidemiological Association 2001 Printed in
Great Britain International Journal of Epidemiology 2001;30:30–42g the 
U-shaped curve. Lancet 1988;ii:1268–73.
29 Drever F, Whitehead M. Health Inequalities: Decennial Supplement.
Series DS No.15, London: The Stationery Office, Office for National
Statistics, 1997.
30 Bofetta P, Garfinkel L. Alcohol; drinking and mortality among men
enrolled in the American Cancer Society prospective study. Epidemiol
1990;1:342–48.
31 Thun MJ, Peto R, Lopez AD et al. Alcohol consumption and mortality
among middle-aged and elderly US adults. N Engl J Med 1997;337:
1705–14.
32 Griffith Edwards et al. Alcohol Policy and the Public Good, 1st edn. New
York: Oxford University Press, 1994.
33 Marmot MG. A not-so-sensible drinks policy. Lancet 1995;346:1643–44.
34 Colhoun H, Ben-Shlomo Y, Dong W, Bost L, Marmot M. Ecological
analysis of collectivity of alcohol consumption in England: importance
of average drinker. Br Med J 1997;314:1164–68.
© International Epidemiological Association 2001 Printed in Great Britain International Journal of Epidemiology 2001;30:734–737
Commentary: Alcohol, coronary heart disease
and public health: which evidence-based
policy?
Pascal Bovet and Fred Paccaud
University Institute of Social and Preventive Medicine, Bugnon 17, 1005
Lausanne, Switzerland.
ALCOHOL, CHD AND PUBLIC HEALTH 735
of disease that can be improved or worsened by alcohol.17
Moderate alcohol intake reduces the relative risk of CHD and
ischaemic stroke but alcohol consumption has a linear relation-
ship with mortality from hepatic cirrhosis, injury from external
causes, haemorrhagic stroke,3,6,18 upper digestive tract cancers
and probably breast cancer19 and large-bowel cancer.20 Hence,
the reduction in all-cause mortality among middle-aged and
elderly people associated with light to moderate alcohol intake
(15–50 g, typically 1–3 drinks) is related to the distribution of
deaths from cardiovascular disease and from conditions poten-
tially worsened by alcohol. For example, among the 226 871
men aged 56 years on average and free of cancer and cirrhosis
at baseline (among whom one drink per day was associated
with a 20% reduction in all-cause mortality), 47% of the 25 424
deaths occurring during 9-year follow-up were due to cardio-
vascular conditions while only 10% were due to conditions
potentially worsened by alcohol.5 In a recent cohort of 1536
Italian middle-aged men followed for 30 years, age-adjusted life
expectancy was 2 years longer for men drinking 49–84 g alcohol
per day (typically 3–6 drinks) than for men drinking 0–12 g 
per day (a similar 2-year longer life expectancy was found for
non-smokers compared to smokers).21
In contrast to the situation in the middle-aged, moderate
drinking is generally associated with increased all-cause
mortality in young adults as mortality in this age group results
mainly from violent deaths (accidents, suicide, homicide) which
are all worsened by alcohol. For example, moderate drinking
was associated with a 30–50% increase in all-cause mortality 
in a cohort study of 49 618 young Swedish military conscripts
in which there were only 38 fatalities from myocardial infarction
among a total of 1473 deaths over a 25-year follow-up.22 This
and other studies17 suggest that benefits of moderate alcohol
intake may outweigh harm among men in their 40s and women
in their 50s.
Irrespective of age, more benefit (in terms of absolute risk)
will result from moderate alcohol intake in people with multiple
cardiovascular risk factors. Conversely, more harm will result
from moderate alcohol consumption in populations with high
rates of deaths from external causes or alcohol-related diseases.
Also worthy of consideration is the fact that populations with
low CHD mortality (which relates inversely with alcohol intake)
tend to have high death rates from haemorrhagic stroke (which
relates directly with alcohol intake). Hence, it is no surprise that
alcohol consumption results in a heavier burden of disease in
developing countries (low CHD mortality, high mortality from
haemorrhagic stroke and injury, demographically young popu-
lations) than in western countries (where opposite characteristics
are found).23
A causal interpretation of the inverse relation between
moderate alcohol consumption and CHD is supported by con-
sistent evidence linking alcohol intake with several factors asso-
ciated with CHD, particularly high density lipoprotein (HDL)
cholesterol and apolipoprotein AI. A recent meta-analysis of 
42 experimental studies demonstrates that moderate alcohol
drinking substantially reduces HDL cholesterol, apo A lipo-
protein, lipoprotein(a), fibrinogen, plasminogen and tissue 
type plasminogen activator antigen.24 On the basis of published
studies (considering that no single study has simultaneously
calculated the risk of CHD associated with all biological factors),
the authors calculated that an intake of 30 g alcohol a day
would cause a 25% reduction in risk of CHD. However, it has
been suggested that alcohol preferentially increases a type of
HDL particles (LpAI:AII) that are less clearly associated with
cardioprotection.25,26 This issue is not yet fully clarified and
needs further research. Cardioprotection from moderate alcohol
consumption has also been challenged on the grounds that
alcohol intake increases blood pressure. However, while 
heavy alcohol intake (e.g. .4 drinks/day) is known to induce
hypertension,27,28 the response is less clear at levels of light-to-
moderate intake.
An inverse relationship between alcohol intake and CHD has
been described in populations with widely different traditional
consumption patterns of alcoholic beverages, suggesting a com-
mon effect of ethanol. However, several studies have suggested
a larger effect of grape or rice wine over other beverages,8,9,29
although a reduced risk of CHD has also been demonstrated for
beer30,31 or spirit.2 The issue is complicated because, in several
countries, wine drinkers tend to be better educated, earn more,
have a healthier diet, and get more medical care; thus, they
tend to have different risks of diseases and different drinking
patterns compared to other drinkers. Wine, unlike most other
alcoholic beverages, contains phenolic substances that are
known to inhibit oxidation of low-density lipoprotein,32 affect
platelet functions33 and inhibit stages of carcinogenesis.34
The different effects of alcoholic beverages could also relate to
nitrosamine, a potentially carcinogenic substance, which is found
in beer and spirits but insignificantly in wine.35 A recent large
Danish cohort study found that upper digestive tract cancers
were strongly associated with beer and even more so with
spirits while no consistent relation was found for wine intake.36
Violent deaths were found to be less frequent in wine drinkers
than in beer drinkers.37 Further research should clarify the role
of substances other than ethanol in different beverage types and
characteristics of drinkers of specific beverages. Such factors
could explain part of the variation in mortality from alcohol-
related diseases between populations.
Drinking pattern has specific health consequences irrespective
of total alcohol intake. A Finnish population-based prospective
study showed, for example, that beer bingeing was associated
with increased all-cause mortality, deaths from external causes,
and fatal myocardial infarctions regardless of the total average
consumption of beer, wine and spirits.38 Binge drinking may
also partly explain the lack of reduced CHD mortality in a cohort
of Scottish middle-aged men39 and may be a key factor in the
current rise in mortality in Eastern European countries.40 In
contrast to binge drinking, regular alcohol consumption with
meals might result, for example, in slowed alcohol absorption,
lower blood alcohol, less alcohol-related damage and more sus-
tained stimulation of high-density lipoproteins. The relationship
between alcohol intake and CHD and all-cause mortality is there-
fore likely to differ among populations where binge drinking
and spirit consumption are common as compared to populations
where regular moderate drinking of wine is predominant.
Societies largely rely on historical, cultural and religious
attitudes for their stances toward alcohol consumption. There
are ‘temperance’ cultures (e.g. UK, Scandinavia) and ‘non-
temperance’ cultures (e.g. France, Italy, Belgium). Alcohol con-
sumption per capita is twice as high in the latter but Alcoholics
Anonymous groups are four times higher in the former.41 An
average of 21 drinks per week may appear as quite ordinary
drinking in the latter but define a ‘problem drinker’ in the
former. Religious beliefs may acquiesce with moderate drinking
(Saint Paul advised to ‘use a little wine for thy stomach’s sake’)
while others (typically Protestant and Islamic religions) favour
abstinence. More subtle influences are also likely. Authors of
publications demonstrating substantial benefits from moderate
alcohol intake have often refrained, unusually, from general-
izing their findings, while moderate alcohol consumption was
an explicit criterion for a healthy lifestyle in a recent large
American primary prevention study using diet and lifestyle.42
It is therefore important to acknowledge that interpretation 
of data and subsequent recommendations related to alcohol
consumption can be influenced to various extents by societal
and cultural preferences.
However, from an epidemiological point of view, the evidence
currently available is large enough to guide recommendations
on alcohol consumption. A net health benefit can be expected
in people aged at least 40 and drinking no more than 2–3 drinks
a day. How long moderate alcohol consumption must continue
for these benefits to occur is however unknown. Benefits are
accrued in people who are at high risk of CHD; conversely, 
the health risk of individuals at low risk of CHD is potentially
worsened by alcohol intake. In that sense, the available
evidence does not point to a universal threshold for a safe (less
so preventive) alcohol intake that would apply to all adults, as
is often suggested. In addition, old prescriptions still hold: one
should abstain from drinking in case of pregnancy, personal or
family history of alcoholism, when taking a medication that
interacts with alcohol or when planning to drive or engage in
other activities that require one to be alert. Therefore no simple
recommendations can be advised for alcohol consumption.
Because the risk reduction in CHD mortality associated with
moderate alcohol intake can be as large as that associated with
cardioprotective drugs (e.g. aspirin, beta-blockers or cholesterol-
lowering drugs), individual advice for moderate consumption of
alcohol, and preferably wine, should be considered for patients
at high risk of CHD and without contraindications. This includes
in particular patients who have had myocardial infarction.43
An approach based on absolute risk has similarly influenced the
rationale of recent guidelines for the clinical management of
raised blood pressure, dyslipidaemia and, generally, CHD.44,45
Possible strategies in this field include the provision of clear
information on the benefits and harms of alcohol consumption,
which should be an integral part of health education program-
mes for health professionals, the general public and children. 
At the same time, innovative approaches to strengthen social
norms protecting against alcohol problems should be developed.
Knowledge-based orientation to prevention may be of particular
importance in young adults to clarify the ambivalence found 
in many societies about alcohol and drinking, e.g. institutional
perspectives encouraging abstinence in teenagers but experi-
mentation in young adults.46 These strategies would be better
than the current propagation of mixed messages or simplistic
views, including the misleading claim that ‘a small amount of
alcohol is safe’ (achieved through skilful marketing by the
industry), and the numerous and many-sided information
channels currently available.
Any strategy in this field should be carefully monitored 
and evaluated. Although promotion of regular drinking of small
amounts of alcohol restricted to specific population segments
seems attractive, it is hardly feasible. Noticeably, no trial has yet
assessed whether increased problem drinking would outweigh
the benefit of reduced CHD mortality if regular drinking of small
amounts of alcohol were to be advocated for specific population
subgroups. Specifically, longitudinal studies should gather more
information on who would start drinking, who would maintain
light-to-moderate drinking and who would progress to heavier
or hazardous drinking.
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